June 26, 2018 | Med Tech, Wilmington Healthcare, healthcare
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
Wilmington Healthcare appoints new Commercial Director
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
In her new post, Sue will lead Wilmington Healthcare’s MedTech services, which include healthcare data, education, information and analytics. She will also oversee a number of key accounts.
Having worked in sales, marketing and business management roles in healthcare for nearly 20 years, Sue has joined Wilmington Healthcare from Veeva Systems, where she was Global Director for Customer Success.
Prior to that, she was Global Strategic Account Director for Zinc Ahead Ltd, where she was the global point of contact for key corporate contacts. The company was acquired by Veeva in September 2015.
Other roles that Sue has held include Product Manager, Anaesthesia & Critical Care, UK, for Baxter Healthcare UK, responsible for the company’s pharmaceutical and medical devices portfolio.
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in sales, marketing and business management roles within the healthcare industry for nearly 20 years, Sue will be a great asset to the MedTech team.
“Medtech is a key sector within our portfolio and Sue will play a key role in helping our clients to better understand the challenges they face, exploit their knowledge and expertise, and optimise their business success.”
Ends
Notes to Editors
For more information, please contact: Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma
A report by healthcare intelligence provider Wilmington Healthcare and the charity, United Kingdom Acquired Brain Injury Forum (UKABIF), shows that many hospital admissions in England for Traumatic Brain Injury (TBI)...
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the impact that STPs will have on the NHS and what this means for pharma.
Laurence Mascarenhas, of Wilmington Healthcare, assesses how pharma can help the NHS to achieve Parity of Esteem (PoE) in mental health
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.